A monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue • Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About • Industry Watch – Developments with COVID-19 and Other Testing • M&A, Distribution, Partnerships Tracked and Charted • New Product Introductions and Company Announcements • Company Profiling and Quarterly Results Summaries • Regional Market Coverage
Page Count: 43
Table of Contents
Market Analysis: Clinical Chemistry
Overview of Clinical Chemistry Market
Market Outlook
Major Product Activity
Regional Market
Top Company Briefs
Roche
Abbott
Danaher
Executive News Briefing
Briefs
QuidelOrtho Makes Changes in Leadership
Roche Appoints New President and CEO of Roche Diagnostics N.A.
Senzo Captures $1.9 Million in Additional Funding
Financial Highlights: Chembio Diagnostics, Guardant Health & Veracyte
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Selected Partnerships and Collaborations
Mergers and Acquisitions
Industry Watch
COVID-19 Update
Region Watch
Croatia
Egypt
Sweden
Broad-based Company Announcements
Announcements
Roche Receives Clearance for Two Alzheimer’s Assays
In Vitro Diagnostics (IVD) is an enormous market and having comprehensive information on the state of IVD and its future is a vital part of making well-informed decisions. The 15th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests…